创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

张温乐, 于怡萌, 雷轶, 戴雪喻, 李斌. 调节性T细胞免疫疗法在自身免疫疾病治疗和移植免疫中的应用[J]. 药学进展, 2023, 47(1): 35-42. DOI: 10.20053/j.issn1001-5094.2023.01.004
引用本文: 张温乐, 于怡萌, 雷轶, 戴雪喻, 李斌. 调节性T细胞免疫疗法在自身免疫疾病治疗和移植免疫中的应用[J]. 药学进展, 2023, 47(1): 35-42. DOI: 10.20053/j.issn1001-5094.2023.01.004
ZHANG Wenle, YU Yimeng, LEI Yi, DAI Xueyu, LI Bin. Application of Treg Cell Immunotherapy in the Treatment of Autoimmune Diseases and Transplantation Immunity[J]. Progress in Pharmaceutical Sciences, 2023, 47(1): 35-42. DOI: 10.20053/j.issn1001-5094.2023.01.004
Citation: ZHANG Wenle, YU Yimeng, LEI Yi, DAI Xueyu, LI Bin. Application of Treg Cell Immunotherapy in the Treatment of Autoimmune Diseases and Transplantation Immunity[J]. Progress in Pharmaceutical Sciences, 2023, 47(1): 35-42. DOI: 10.20053/j.issn1001-5094.2023.01.004

调节性T细胞免疫疗法在自身免疫疾病治疗和移植免疫中的应用

Application of Treg Cell Immunotherapy in the Treatment of Autoimmune Diseases and Transplantation Immunity

  • 摘要: 调节性T细胞(Treg)在抑制靶向自身抗原的免疫细胞的活性以及控制自身免疫病导致的炎症中起到十分重要的作用,通过Treg细胞扩增,以及其免疫抑制功能的手段来治疗自身免疫疾病和器官移植颇具前景。目前,Treg细胞疗法在移植物抗宿主病(GVHD)、自身免疫病的表现受到广泛关注,其治疗潜力正在多项自身免疫病相关的临床试验中获得验证。通过对Treg细胞疗法在自身免疫病和器官移植中的应用进展进行综述,以期为Treg细胞疗法的研究提供参考。

     

    Abstract: Regulatory T cells(Treg) play an important role in inhibiting the activity of immune cells targeting self-antigens and controlling inflammation caused by autoimmune diseases. Expanding Treg cells and taking advantage of their immunosuppressive function are promising means for the treatment of autoimmune diseases and organ transplantation. Currently, Treg cell therapy in graft-versus-host disease (GVHD) and autoimmune diseases has received wide attention, and its therapeutic potential is being verified in a number of clinical trials related to autoimmune diseases. The application advances of Treg cell therapy in autoimmune diseases and organ transplantation are reviewed in order to provide some reference for the research on Treg cell therapy.

     

/

返回文章
返回